Alternative Pathways to Licensure for West Nile Virus Vaccines

We're in a better position now to pursue alternative pathways to licensure compared with when the early clinical trials of West Nile vaccine candidates were completed. We have four licensed flavivirus vaccines in the United States now. So we're not starting from scratch. There are, as you mentioned, several alternative pathways that could be reasonable options for West Nile development.